Over a month ago
Recommendations
Ladenburg analyst Jeffrey…
Ladenburg analyst Jeffrey Cohen lowered the firm's price target on Opko Health to $5.40 from $5.75 and keeps a Buy rating on the shares post the Q1 results. The analyst is encouraged by the company's partnerships established to progress its clinical and regulatory efforts.
Show Hide Related Items >> <<
03/08/23 Opko Health enters exclusive worldwide license agreement with Merck 12/15/22 H.C. Wainwright Opko Health initiated with a Buy at H.C. Wainwright 08/04/22 Piper Sandler Opko Health price target lowered to $4 from $5 at Piper Sandler 05/10/22 Piper Sandler Opko Health price target lowered to $5 from $6 at Piper Sandler 05/03/23 Opko Health reports Q1 EPS (2c), consensus (8c) 02/23/23 Opko Health reports Q4 EPS (11c), consensus (11c) 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning
Earnings
Reports Q1 revenue…
Reports Q1 revenue $237.6M, consensus $193.35M. Cash and cash equivalents were $110.8M as of March 31, which does not include the $50m upfront payment from Merck that was received in April.
Show Hide Related Items >> <<
03/08/23 Opko Health enters exclusive worldwide license agreement with Merck 12/15/22 H.C. Wainwright Opko Health initiated with a Buy at H.C. Wainwright 08/04/22 Piper Sandler Opko Health price target lowered to $4 from $5 at Piper Sandler 05/10/22 Piper Sandler Opko Health price target lowered to $5 from $6 at Piper Sandler 02/23/23 Opko Health reports Q4 EPS (11c), consensus (11c) 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning
Conference/Events
Virtual Meeting to be…
Virtual Meeting to be held on March 24 hosted by Piper Sandler.
Show Hide Related Items >> <<
03/08/23 Opko Health enters exclusive worldwide license agreement with Merck 10/05/22 Aspira Women's Health announces launch of collaboration with BioReferenceOpko Health 12/15/22 H.C. Wainwright Opko Health initiated with a Buy at H.C. Wainwright 08/04/22 Piper Sandler Opko Health price target lowered to $4 from $5 at Piper Sandler 05/10/22 Piper Sandler Opko Health price target lowered to $5 from $6 at Piper Sandler 02/23/23 Opko Health reports Q4 EPS (11c), consensus (11c) 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning
Conference/Events
Virtual Meeting to be…
Virtual Meeting to be held on March 24 hosted by Piper Sandler.
Show Hide Related Items >> <<
03/08/23 Opko Health enters exclusive worldwide license agreement with Merck 10/05/22 Aspira Women's Health announces launch of collaboration with BioReferenceOpko Health 12/15/22 H.C. Wainwright Opko Health initiated with a Buy at H.C. Wainwright 08/04/22 Piper Sandler Opko Health price target lowered to $4 from $5 at Piper Sandler 05/10/22 Piper Sandler Opko Health price target lowered to $5 from $6 at Piper Sandler 02/23/23 Opko Health reports Q4 EPS (11c), consensus (11c) 03/08/23 What You Missed On Wall Street On Wednesday 03/08/23 What You Missed On Wall Street This Morning
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
03/06/23 WW to acquire Sequence for $132M in cash, stock 03/03/23 S&P announces changes to S&P 600 index at open on 3/20 11/30/22 WW announces departure of CFO Amy O'Keefe 11/14/22 Google debuts Health Connect beta, supports Peloton, Oura, WeightWatchers apps 03/08/23 Essential Utilities falls 2% to $40.70 after Spruce Point short report 01/11/23 Essential Utilities' Aqua Ohio agrees to purchase URS system for $25.5M 01/03/23 Essential Utilities to sell West Virginia gas utility assets to Hope Gas 11/08/22 Essential Utilities says Jeanne Russo joins as VP communications ,Nair as CIO 03/08/23 Vera Bradley committed to returning Vera Bradley, Pura Vida to profitable growth 01/24/23 Vera Bradley announces Alison Hiatt joins as Chief Marketing Oficer 01/24/23 Vera Bradley eliminates CCO, CRO and president roles in leadership streamlining 12/07/22 Vera Bradley appoints Jackie Ardrey as president, CEO UNFI United Natural Foods $29.53 / -11.445 (-27.94%)
03/08/23 United Natural Foods falls -25.8% 03/08/23 United Natural Foods falls -32.9% 03/08/23 United Natural Foods falls -31.6% 03/08/23 United Natural Foods falls 20% to $32.51 after cutting FY23 EPS outlook 03/06/23 Tesla issues recall notice for 3,470 Model Y vehicles in U.S. 02/27/23 Tesla temporarily halts FSD beta software installations until recall addressed 02/24/23 SEC says Elon Musk still needs lawyer to approve tweets 02/22/23 Tesla to announce move to 'California Engineering Headquarters' SPY SPDR S&P 500 ETF Trust 11/14/22 Jana made new buy Freshpet top holding in Q3, also bought Momentive 03/01/23 Einhorn says not invested long in artificial intelligence companies 12/14/22 SEC proposes rules to enhance competition for retail order flow execution 11/07/22 SEC Chief Prashant Yerramalli departing Dec. 31, Amanda Fischer to replace 03/06/23 Silvergate Capital falls -9.6% 03/06/23 Silvergate falls after discontinuing Silvergate Exchange Network 03/03/23 Silvergate Capital falls -6.4% 03/02/23 Silvergate Capital falls -44.7% RIGL Rigel Pharmaceuticals 02/02/23 Rigel announces publication summarizing results from Phase 2 study of REZLIDHIA 01/18/23 Rigel Pharmaceuticals: NCCN adds REZLIDHIA to clinical practice guidelines 12/22/22 Rigel Pharmaceuticals says REZLIDHIA now available in U.S. by prescription 12/15/22 Rigel Pharmaceuticals doses first patient in Phase 1b study of R289 03/08/23 Piedmont Lithium down 4% following Blue Orca short report 02/16/23 LG Chem to make $75M investment in Piedmont, commits to offtake pacts 01/04/23 Piedmont Lithium expands board to seven directors 01/03/23 Piedmont Lithium jumps 9% to $47.99 after amended pact with Tesla 03/08/23 Opko Health enters exclusive worldwide license agreement with Merck 10/05/22 Aspira Women's Health announces launch of collaboration with BioReferenceOpko Health 12/28/22 Minerva announces FDA refusal of NDA for roluperidone 10/17/22 Minerva trading resumes 10/17/22 Minerva to resume trading at 09:00 ET 10/17/22 Minerva recieves refusal to file letter from FDA for roluperidone NDA 03/06/23 Merck says MK-0616 'significantly reduced' LDL-C in Phase 2b study 03/06/23 Merck: FDA approves IM route of administration for MMRV family of vaccines 03/02/23 Illumina and Myriad Genetics partner for HRD testing in the U.S. 03/06/23 Medtronic's PulseSelect PFA System exceeds safety performance goal in trial 02/24/23 Medtronic announces one-year data from ADAPT study of MiniMed 780G system 02/21/23 Medtronic sees Q4 organic revenue up 4.5%-5% 02/17/23 Medtronic receives CE Mark for extravascular defibrillator system 01/05/23 SunPower, Maxeon Solar extend current supply relationship 12/28/22 Maxeon Solar appoints Bill Mulligan as CEO, member of board 10/17/22 Maxeon Solar expands SunPower One ecosystem to EV charging 11/03/22 LifeStance appoints David Bourdon as CFO 03/02/23 Nordstrom up 2% following Q4 report 03/02/23 Nordstrom announces wind-down of Canadian business 02/06/23 Nordstrom falls -11.5% 02/03/23 Nordstrom rises 18.4% 02/21/23 EU passenger car registrations up 11.3% in January 02/21/23 General Motors subsidiary, Tawazun Council sign cooperation agreement 02/15/23 GM, EVgo to build 2,000 high power fast chargers along American highways 02/15/23 White House announces progress for national network of EV chargers 12/08/22 Edwards Lifesciences CEO Michael Mussallem to retire, Bernard Zovighian succeeds 11/01/22 Edwards Lifesciences authorizes $750M accelerated share repurchase 10/28/22 Edwards Lifesciences falls -16.6% 10/28/22 Edwards Lifesciences falls -14.3% 03/08/23 Diversey will not provide financial guidance, host earnings conference call 03/08/23 Diversey to be acquired by Solenis for $8.40 per share in cash 03/08/23 Diversey shareholders to receive $8.40 per share in cash in go private deal 03/08/23 Diversey to be acquired by Solenis in deal valued at enterprise value of $4.6B 01/17/23 Crowdstrike adds two executives to its leadership team 12/29/22 Crowdstrike director Austin buys $2.5M in company shares 12/01/22 Crowdstrike CEO: Most companies would kill for our results 11/30/22 Cathie Wood's ARK Investment bought 39.2K shares of Crowdstrike today 01/25/23 Campbell Soup names Carrie Anderson as new CFO 01/18/23 Campbell Soup: No commercial roles being eliminated related to office closings 01/18/23 Campbell Soup to consolidate snacks offices, invest $50M in Camden headquarters 01/18/23 Campbell Soup to consolidate snacks offices, invest $50M in Camden headquarters 03/07/23 Vita Coco appoints Corey Baker as CFO 02/09/23 Vita Coco to deliver free hangover recovery after the Big Game 01/30/23 Vita Coco launches Vita Coco Barista MLK with Alfred Coffee 03/06/23 Cara sees cash, cash equivalents sufficient to fund ops into at least 1H24 02/08/23 Cara Therapeutics announces results from Phase 2 trial of oral Difelikefalin 11/29/22 KemPharm appoint Christopher Posner to board of directors 11/03/22 Cara Therapeutics appoints Lisa von Moltk to board of directors $16.40 / -2.135 (-11.52%)
03/06/23 BridgeBio announces Phase 2 cohort 5 results of infigratinib 02/23/23 BridgeBio sees cash runway into 2024 02/17/23 BridgeBio reports inducement grants under Nasdaq listing rule 12/22/22 BridgeBio initiates Phase 3 trial CALIBRATE study of encaleret 02/06/23 Couchbase names Fidelma Butler as Chief People Officer 02/06/23 Couchbase names Fidelma Butler as Chief People Officer 11/29/22 Couchbase announces multi-year strategic collaboration agreement with AWS 11/28/22 Couchbase selected by Arthrex to improve patient outcomes $619.12 / +10.23 (+1.68%)
02/15/23 ASML discloses data misappropriation by former employee in China 02/14/23 Lone Pine exited PayPal, initiated AMD position during Q4 11/16/22 Wafer Fab Equipment names slide after Micron cuts wafer starts 11/10/22 ASML up 10% to $539.48 after buyback, outlook at investor day 03/08/23 Arlo Technologies rises 44.3% 03/08/23 Arlo Technologies rises 28.3% 03/08/23 Arlo Technologies rises 16.5% 11/09/22 Arlo Technologies falls -31.9% 03/01/23 Einhorn says investors should be 'bearish on stocks and bullish on inflation' 03/08/23 Macquarie Piedmont Lithium initiated with Outperform, $140 target at Macquarie 03/08/23 Macquarie Piedmont Lithium initiated with an Outperform at Macquarie 12/02/22 DA Davidson Piedmont Lithium price target raised to $90 from $85 at DA Davidson 10/27/22 B. Riley Piedmont Lithium assumed with a Buy at B. Riley 03/06/23 Compass Point Silvergate Capital downgraded to Sell from Neutral at Compass Point 03/06/23 Wedbush Wedbush downgrades Silvergate Capital to Underperform, lowers price target to $4 03/06/23 Wedbush Silvergate Capital downgraded to Underperform from Neutral at Wedbush 03/02/23 Goldman Sachs Goldman suspends Silvergate rating on 'insufficient information' 03/08/23 Deutsche Bank Crowdstrike price target raised to $130 from $115 at Deutsche Bank 03/08/23 Wedbush Crowdstrike price target raised to $145 from $135 at Wedbush 03/08/23 Stifel Crowdstrike price target raised to $125 from $110 at Stifel 03/08/23 Stephens Crowdstrike price target raised to $173 from $161 at Stephens 12/20/22 Morgan Stanley Campbell Soup price target raised to $57 from $56 at Morgan Stanley 12/08/22 RBC Capital Campbell Soup price target raised to $50 from $46 at RBC Capital 12/08/22 Morgan Stanley Campbell Soup price target raised to $56 from $48 at Morgan Stanley 12/08/22 Piper Sandler Campbell Soup price target raised to $55 from $46 at Piper Sandler 03/09/23 BMO Capital Diversey price target raised to $8.40 from $5.80 at BMO Capital 03/09/23 Morgan Stanley Diversey downgraded to Equal Weight from Overweight at Morgan Stanley 02/22/23 BofA Diversey reinstated with an Underperform at BofA amid near-term challenges 02/22/23 BofA Diversey reinstated with an Underperform at BofA UNFI United Natural Foods $29.53 / -11.445 (-27.94%)
03/09/23 Wells Fargo United Natural Foods price target lowered to $28 from $40 at Wells Fargo 03/09/23 BMO Capital United Natural Foods price target lowered to $28 from $40 at BMO Capital 03/08/23 Roth MKM Roth MKM downgrades United Natural Foods after 'large' earnings miss 03/08/23 Roth MKM United Natural Foods downgraded to Neutral from Buy at Roth MKM 03/07/23 JPMorgan JPMorgan says 'spooked' Powell opened door to 50 point hike 02/13/23 JPMorgan Stock market risk/reward 'skewed to the downside,' says JPMorgan 02/07/23 Morgan Stanley Morgan Stanley sees 25 point rate hikes coming from Fed in March and May 02/06/23 JPMorgan JPMorgan sees 25 basis point rate hikes in March and May SPY SPDR S&P 500 ETF Trust 03/08/23 Citi Tesla comments 'very bullish' for lithium industry, says Citi 03/08/23 Berenberg Tesla downgraded to Hold from Buy at Berenberg 03/06/23 Morgan Stanley Ferrari replaces Tesla as Morgan Stanley top pick in autos 03/06/23 Jefferies Tesla price target raised to $230 from $180 at Jefferies 03/08/23 Argus Nordstrom upgraded to Buy from Hold at Argus 03/03/23 Morgan Stanley Nordstrom assumed with an Underweight at Morgan Stanley 02/24/23 Citi Nordstrom price target raised to $20 from $17 at Citi 02/24/23 Barclays Nordstrom price target lowered to $16 from $18 at Barclays 03/08/23 Craig-Hallum Craig-Hallum downgrades WW to Sell, sees stock outperformance as overreaction 03/08/23 DA Davidson WW price target raised to $9 from $6 at DA Davidson 03/08/23 Craig-Hallum WW downgraded to Sell from Hold at Craig-Hallum 11/08/22 DA Davidson WW price target lowered to $6 from $15 at DA Davidson 03/07/23 BofA Cara Therapeutics downgraded to Underperform from Neutral at BofA 03/07/23 Needham Cara Therapeutics price target lowered to $22 from $26 at Needham 03/07/23 Canaccord Cara Therapeutics price target lowered to $25 from $29 at Canaccord 03/07/23 H.C. Wainwright Cara Therapeutics price target lowered to $20 from $25 at H.C. Wainwright 03/08/23 Wells Fargo Wells downgrades Edwards Lifesciences with Medtronic gaining share 03/08/23 Wells Fargo Edwards Lifesciences downgraded to Equal Weight from Overweight at Wells Fargo 02/06/23 Raymond James Edwards Lifesciences downgraded to Market Perform from Outperform at Raymond James 02/06/23 Raymond James Edwards Lifesciences downgraded to Market Perform at Raymond James 02/22/23 Deutsche Bank Medtronic price target raised to $87 from $80 at Deutsche Bank 01/31/23 Bernstein Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein 01/24/23 Mizuho Medtronic price target lowered to $95 from $100 at Mizuho 02/06/23 UBS Essential Utilities upgraded to Buy from Neutral at UBS 02/06/23 UBS Essential Utilities upgraded to Buy from Neutral at UBS 09/09/22 BofA Essential Utilities downgraded to Neutral at BofA following PA setbacks 09/09/22 BofA Essential Utilities downgraded to Neutral from Buy at BofA 03/09/23 Citi WSJ report on GM didn't contain new information, says Citi 02/24/23 BofA GM should be bought, not sold, on truck production cut, says BofA 02/15/23 Needham GlobalFoundries price target raised to $80 from $72 at Needham 02/14/23 Barclays Barclays starts autos and mobility sector, says Tesla stands out $619.12 / +10.23 (+1.68%)
01/26/23 Barclays ASML price target lowered to EUR 665 from EUR 680 at Barclays 01/26/23 Credit Suisse ASML price target raised to EUR 767 from EUR 752 at Credit Suisse 01/26/23 Deutsche Bank ASML price target raised to EUR 675 from EUR 650 at Deutsche Bank 01/26/23 Argus ASML price target raised to $775 from $590 at Argus 03/08/23 Roth MKM Maxeon Solar price target raised to $21 from $19 at Roth MKM 03/08/23 Northland Maxeon Solar price target raised to $31 from $24 at Northland 03/08/23 Raymond James Maxeon Solar price target raised to $24 from $22 at Raymond James 01/04/23 Raymond James Maxeon Solar upgraded to Outperform from Market Perform at Raymond James 11/09/22 BWS Financial Arlo Technologies price target lowered to $8 from $15 at BWS Financial 08/10/22 Lake Street Arlo Technologies price target raised to $16 from $14 at Lake Street 01/06/23 Morgan Stanley LifeStance upgraded at Morgan Stanley on confidence in new management 01/06/23 Morgan Stanley LifeStance upgraded to Overweight from Equal Weight at Morgan Stanley 11/14/22 TD Cowen LifeStance price target lowered to $8 from $10 at Cowen 11/07/22 Jefferies LifeStance assumed with a Buy at Jefferies 12/15/22 H.C. Wainwright Opko Health initiated with a Buy at H.C. Wainwright 08/04/22 Piper Sandler Opko Health price target lowered to $4 from $5 at Piper Sandler 05/10/22 Piper Sandler Opko Health price target lowered to $5 from $6 at Piper Sandler 03/08/23 Cantor Fitzgerald SoundHound price target raised to $3.20 from $1.60 at Cantor Fitzgerald 01/06/23 Northland SoundHound price target lowered to $4.50 from $6 at Northland 11/30/22 Cantor Fitzgerald SoundHound upgraded to Overweight from Neutral at Cantor Fitzgerald 11/30/22 Cantor Fitzgerald SoundHound upgraded to Overweight from Neutral at Cantor Fitzgerald 03/07/23 Jefferies Sotatercept data supports bullish view of Merck cardio franchise, says Jefferies 03/07/23 Mizuho Merck cardiovascular franchise set for 'resurgence,' says Mizuho 03/07/23 Raymond James Gossamer Bio downgraded to Market Perform from Outperform at Raymond James 03/06/23 Jefferies Merck initiated with a Buy at Jefferies $16.40 / -2.135 (-11.52%)
03/07/23 BofA Ascendis Pharma has positive read-through from BridgeBio data, says BofA 03/07/23 BofA Tyra Biosciences has positive read-through from BridgeBio data, says BofA 03/07/23 BofA BridgeBio price target raised to $18 from $15 at BofA 03/06/23 Oppenheimer Opco views BridgeBio data as good news for Tyra Biosciences RIGL Rigel Pharmaceuticals 03/09/23 Citi Rigel Pharmaceuticals price target raised to $3 from $2 at Citi 12/02/22 Citi Citi upgrades Rigel to Buy after leukemia approval comes earlier 12/02/22 Citi Rigel Pharmaceuticals upgraded to Buy from Neutral at Citi 08/18/22 H.C. Wainwright Rigel Pharmaceuticals price target raised to $15 from $7 at H.C. Wainwright 03/08/23 Morgan Stanley Couchbase conservatism may set up continued quarterly beats, says Morgan Stanley 03/08/23 Stifel Couchbase price target raised to $19 from $17 at Stifel 03/08/23 Baird Couchbase price target raised to $20 from $18 at Baird 02/15/23 Barclays Couchbase price target raised to $19 from $16 at Barclays 12/15/22 Piper Sandler Vita Coco price target raised to $17 from $13 at Piper Sandler 07/08/22 BofA Vita Coco upgraded to Buy at BofA as ocean freight costs ease 07/08/22 BofA Vita Coco upgraded to Buy from Neutral at BofA 05/16/22 Piper Sandler Vita Coco price target lowered to $15 from $17 at Piper Sandler 06/16/22 Noble Capital Vera Bradley initiated with an Outperform at Noble Capital 11/10/22 H.C. Wainwright Minerva downgraded to Neutral from Buy at H.C. Wainwright 10/17/22 JMP Securities Minerva downgraded to Market Perform from Outperform at JMP Securities 08/23/22 H.C. Wainwright Minerva price target lowered to $24 from $40 at H.C. Wainwright 03/06/23 WW sees Q1 revenue $235M, consensus $243.89M 03/06/23 WW reports Q4 EPS (46c), consensus 0c 11/03/22 WW sees 2022 revenue $1.04B, consensus $1.06B 11/03/22 WW reports Q3 EPS with items ($2.93), consensus 36c 01/11/23 Essential Utilities sees FY23 EPS $1.85-$1.90, consensus $1.90 01/11/23 Essential Utilities affirms FY22 EPS view of $1.75-$1.80, consensus $1.79 11/07/22 Essential Utilities backs FY22 EPS $1.75-1.80, consensus $1.78 11/07/22 Essential Utilities reports Q3 EPS 26c, consensus 22c 03/08/23 Vera Bradley sees Q1 revenue in line with prior year 03/08/23 Vera Bradley sees 2024 EPS 40c-50c, two est. 35c 03/08/23 Vera Bradley reports Q4 EPS ex-items 16c vs. 17c last year. 01/24/23 Vera Bradley: Pura Vida co-PresidentsThall and Goodman leaving company UNFI United Natural Foods $29.53 / -11.445 (-27.94%)
03/08/23 United Natural Foods cuts FY23 adjusted EPS view to $3.05-$3.90 from $4.85-$5.15 03/08/23 United Natural Foods reports Q2 adjusted EPS 78c, consensus $1.46 12/07/22 United Natural Foods backs FY23 adjusted EPS view $4.85-$5.15, consensus $5.04 12/07/22 United Natural Foods reports Q1 adjusted EPS $1.13, consensus $1.15 03/02/23 Aehr Test Systems reiterates annual guidance, comments on Tesla statements 01/25/23 Tesla reports Q4 EPS $1.19, consensus $1.13 01/25/23 Notable companies reporting after market close 10/19/22 Tesla reports Q3 EPS $1.05, consensus 99c 03/07/23 SoundHound sees FY23 revenue $43M-$50M, consensus $46.05M 03/07/23 SoundHound reports Q4 EPS (15c), consensus (17c) 11/10/22 SoundHound narrows FY22 revenue view $28M-$32M from $27M-$33M 11/10/22 SoundHound reports Q2 EPS (15c) vs (35c) last year 01/17/23 Silvergate Capital reports Q4 adjusted EPS 48c, consensus 81c 10/18/22 Silvergate Capital reports Q3 EPS $1.28, consensus $1.38 RIGL Rigel Pharmaceuticals 03/07/23 Rigel Pharmaceuticals reports Q4 EPS 1c, consensus (11c) 01/09/23 Rigel Pharmaceuticals sees Q4 revenue $51.3M, consensus $21.65M 11/03/22 Rigel Pharmaceuticals reports Q3 EPS (11c), consensus (13c) 02/23/23 Opko Health reports Q4 EPS (11c), consensus (11c) 03/08/23 Minerva reports Q4 EPS ($1.26), consensus (92c) 11/09/22 Minerva reports Q3 EPS ($1.29), consensus ($1.32) 02/28/23 NGM Biopharmaceuticals reports Q4 EPS (45c), consensus (51c) 02/02/23 Merck sees FY23 adjusted EPS $6.80-$6.95, consensus $7.36 02/02/23 Merck reports Q4 adjusted EPS $1.62, consensus $1.54 02/01/23 Notable companies reporting before tomorrow's open 02/21/23 Medtronic sees Q4 EPS $1.55-$1.57, consensus $1.58 02/21/23 Medtronic narrows FY23 EPS view to $5.28-$5.30 from $5.25-$5.30 02/21/23 Medtronic reports Q3 EPS $1.30, consensus $1.27 11/22/22 Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40 03/07/23 Maxeon Solar sees F23 revenue $1.350B-$1.550B, consensus $1.57B 03/07/23 Maxeon Solar sees Q1 revenue $305M-$345M, consensus $309.53M 03/07/23 Maxeon Solar reports Q4 EPS ($1.84), consensus ($1.27) 11/10/22 Maxeon Solar sees Q4 revenue $290M-$330M, consensus $328.34M 03/08/23 LifeStance sees Q1 revenue $242M-$252M, consensus $234.62M 03/08/23 LifeStance sees FY23 revenue $980M-$1.02B, consensus $972.17M 03/08/23 LifeStance reports Q4 revenue $229.4M, consensus $216.61M 11/08/22 LifeStance sees FY22 revenue $845M-$850M, consensus $868.13M 03/02/23 Nordstrom reports Q4 EPS 74c, consensus 66c 03/02/23 Nordstrom sees FY23 adjusted EPS $1.80-$2.20, consensus $1.93 03/02/23 Notable companies reporting after market close 01/19/23 Nordstrom cuts FY22 adjusted EPS view to $1.50-$1.70 from $2.30-$2.60 01/31/23 General Motors sees FY23 adjusted EPS $6.00-$7.00, consensus $5.81 01/31/23 General Motors reports Q4 adjusted EPS $2.12, consensus $1.69 01/30/23 Notable companies reporting before tomorrow's open 01/31/23 Edwards Lifesciences sees Q1 adjusted EPS 58c-64c, consensus 59c 01/31/23 Edwards Lifesciences backs FY23 adjusted EPS $2.45-$2.60, consensus $2.50 01/31/23 Edwards Lifesciences reports Q4 adjusted EPS 64c, consensus 61c 01/31/23 Notable companies reporting after market close 11/03/22 Diversey sees FY22 mid-single digit percent growth over 2021 11/03/22 Diversey reports Q3 adjusted EPS 9c, consensus 9c 03/07/23 Crowdstrike sees FY24 EPS $2.21-$2.39, consensus $2.00 03/07/23 Crowdstrike sees Q1 EPS 50c-51c, consensus 43c 03/07/23 Crowdstrike reports Q4 adjusted EPS 47c, consensus 43c 03/07/23 Notable companies reporting after market close 03/08/23 Campbell Soup tightens FY23 adjusted EPS view to $2.95-$3.00 from $2.90-$3.00 03/08/23 Campbell Soup reports Q2 EPS 80c, consensus 74c 03/07/23 Notable companies reporting before tomorrow's open 03/08/23 Vita Coco sees FY23 net sales growth 9%-11% 03/08/23 Vita Coco reports Q4 EPS (5c), consensus 5c 11/09/22 Vita Coco sees 2022 revenue $422M-$427M, consensus $448.82M 11/09/22 Vita Coco reports Q3 EPS 13c, consensus 15c 03/06/23 Cara Therapeutics reports Q4 EPS (56c), consensus (32c) 11/07/22 Cara Therapeutics reports Q3 EPS (43c), consensus (42c) $16.40 / -2.135 (-11.52%)
02/23/23 BridgeBio reports Q4 EPS (92c), consensus (85c) 11/03/22 BridgeBio reports Q3 EPS (93c), consensus (99c) 03/07/23 Couchbase sees Q1 revenue $39.5M-$40.1M, consensus $40.63M 03/07/23 Couchbase sees FY23 revenue $171.7M-$174.7M, consensus $176.59M 03/07/23 Couchbase reports Q4 EPS (37c), consensus (34c) $619.12 / +10.23 (+1.68%)
01/25/23 ASML sees FY23 revenue up over 25% vs. FY22 01/25/23 ASML sees Q1 revenue EUR 6.1B-EUR 6.5B, gross margin 49%-50% 01/25/23 ASML reports Q4 EPS EUR 4.60 vs. EUR 4.29 in Q3 11/10/22 ASML sees 2025 revenue EUR 30B to EUR 40B 03/07/23 Arlo Technologies sees Q1 adjusted EPS (7c)-(1c), consensus (7c) 03/07/23 Arlo Technologies reports Q4 adjusted EPS (4c), consensus (10c)
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
03/06/23 WW to acquire Sequence for $132M in cash, stock 03/03/23 S&P announces changes to S&P 600 index at open on 3/20 11/30/22 WW announces departure of CFO Amy O'Keefe 11/14/22 Google debuts Health Connect beta, supports Peloton, Oura, WeightWatchers apps 03/08/23 Essential Utilities falls 2% to $40.70 after Spruce Point short report 01/11/23 Essential Utilities' Aqua Ohio agrees to purchase URS system for $25.5M 01/03/23 Essential Utilities to sell West Virginia gas utility assets to Hope Gas 11/08/22 Essential Utilities says Jeanne Russo joins as VP communications ,Nair as CIO 03/01/23 WeWork teams with pan-African real estate investor SiSebenza, no terms 01/18/23 WeWork, Captivate enter strategic partnership for digital content, advertising 09/13/22 Latch announce collaboration with WeWork 03/08/23 Vera Bradley committed to returning Vera Bradley, Pura Vida to profitable growth 01/24/23 Vera Bradley announces Alison Hiatt joins as Chief Marketing Oficer 01/24/23 Vera Bradley eliminates CCO, CRO and president roles in leadership streamlining 12/07/22 Vera Bradley appoints Jackie Ardrey as president, CEO UNFI United Natural Foods $30.49 / -10.48 (-25.58%)
03/08/23 United Natural Foods falls -25.8% 03/08/23 United Natural Foods falls -32.9% 03/08/23 United Natural Foods falls -31.6% 03/08/23 United Natural Foods falls 20% to $32.51 after cutting FY23 EPS outlook 03/06/23 Tesla issues recall notice for 3,470 Model Y vehicles in U.S. 02/27/23 Tesla temporarily halts FSD beta software installations until recall addressed 02/24/23 SEC says Elon Musk still needs lawyer to approve tweets 02/22/23 Tesla to announce move to 'California Engineering Headquarters' 03/06/23 Silvergate Capital falls -9.6% 03/06/23 Silvergate falls after discontinuing Silvergate Exchange Network 03/03/23 Silvergate Capital falls -6.4% 03/02/23 Silvergate Capital falls -44.7% RIGL Rigel Pharmaceuticals 02/02/23 Rigel announces publication summarizing results from Phase 2 study of REZLIDHIA 01/18/23 Rigel Pharmaceuticals: NCCN adds REZLIDHIA to clinical practice guidelines 12/22/22 Rigel Pharmaceuticals says REZLIDHIA now available in U.S. by prescription 12/15/22 Rigel Pharmaceuticals doses first patient in Phase 1b study of R289 03/08/23 Piedmont Lithium down 4% following Blue Orca short report 02/16/23 LG Chem to make $75M investment in Piedmont, commits to offtake pacts 01/04/23 Piedmont Lithium expands board to seven directors 01/03/23 Piedmont Lithium jumps 9% to $47.99 after amended pact with Tesla 03/08/23 Opko Health enters exclusive worldwide license agreement with Merck 10/05/22 Aspira Women's Health announces launch of collaboration with BioReferenceOpko Health 12/28/22 Minerva announces FDA refusal of NDA for roluperidone 10/17/22 Minerva trading resumes 10/17/22 Minerva to resume trading at 09:00 ET 10/17/22 Minerva recieves refusal to file letter from FDA for roluperidone NDA 03/06/23 Merck says MK-0616 'significantly reduced' LDL-C in Phase 2b study 03/06/23 Merck: FDA approves IM route of administration for MMRV family of vaccines 03/02/23 Illumina and Myriad Genetics partner for HRD testing in the U.S. 03/06/23 Medtronic's PulseSelect PFA System exceeds safety performance goal in trial 02/24/23 Medtronic announces one-year data from ADAPT study of MiniMed 780G system 02/21/23 Medtronic sees Q4 organic revenue up 4.5%-5% 02/17/23 Medtronic receives CE Mark for extravascular defibrillator system 01/05/23 SunPower, Maxeon Solar extend current supply relationship 12/28/22 Maxeon Solar appoints Bill Mulligan as CEO, member of board 10/17/22 Maxeon Solar expands SunPower One ecosystem to EV charging 11/03/22 LifeStance appoints David Bourdon as CFO 03/02/23 Nordstrom up 2% following Q4 report 03/02/23 Nordstrom announces wind-down of Canadian business 02/06/23 Nordstrom falls -11.5% 02/03/23 Nordstrom rises 18.4% 03/06/23 Intel delaying Falcon Shores to 2025, McVeigh says in blog post 02/22/23 Intel provides update on effort to optimize cost structure 02/22/23 Intel reduces quarterly dividend to 12.5c per share 02/15/23 HP announces Z by HP workstation desktop lineup 12/08/22 Edwards Lifesciences CEO Michael Mussallem to retire, Bernard Zovighian succeeds 11/01/22 Edwards Lifesciences authorizes $750M accelerated share repurchase 10/28/22 Edwards Lifesciences falls -16.6% 10/28/22 Edwards Lifesciences falls -14.3% 03/08/23 Diversey will not provide financial guidance, host earnings conference call 03/08/23 Diversey to be acquired by Solenis for $8.40 per share in cash 03/08/23 Diversey shareholders to receive $8.40 per share in cash in go private deal 03/08/23 Diversey to be acquired by Solenis in deal valued at enterprise value of $4.6B 01/17/23 Crowdstrike adds two executives to its leadership team 12/29/22 Crowdstrike director Austin buys $2.5M in company shares 12/01/22 Crowdstrike CEO: Most companies would kill for our results 11/30/22 Cathie Wood's ARK Investment bought 39.2K shares of Crowdstrike today 01/25/23 Campbell Soup names Carrie Anderson as new CFO 01/18/23 Campbell Soup: No commercial roles being eliminated related to office closings 01/18/23 Campbell Soup to consolidate snacks offices, invest $50M in Camden headquarters 01/18/23 Campbell Soup to consolidate snacks offices, invest $50M in Camden headquarters 03/07/23 Vita Coco appoints Corey Baker as CFO 02/09/23 Vita Coco to deliver free hangover recovery after the Big Game 01/30/23 Vita Coco launches Vita Coco Barista MLK with Alfred Coffee 03/06/23 Cara sees cash, cash equivalents sufficient to fund ops into at least 1H24 02/08/23 Cara Therapeutics announces results from Phase 2 trial of oral Difelikefalin 11/29/22 KemPharm appoint Christopher Posner to board of directors 11/03/22 Cara Therapeutics appoints Lisa von Moltk to board of directors 03/08/23 Brown-Forman sees FY23 capital expenditures $190M-$210M 01/12/23 Brown-Forman names Larry Combs chief information officer 12/07/22 Brown-Forman sees FY23 capital expenditures $190M-$210M 12/01/22 Brown-Forman to name Marshall Farrer chief strategic growth officer $15.84 / -2.695 (-14.54%)
03/06/23 BridgeBio announces Phase 2 cohort 5 results of infigratinib 02/23/23 BridgeBio sees cash runway into 2024 02/17/23 BridgeBio reports inducement grants under Nasdaq listing rule 12/22/22 BridgeBio initiates Phase 3 trial CALIBRATE study of encaleret 02/06/23 Couchbase names Fidelma Butler as Chief People Officer 02/06/23 Couchbase names Fidelma Butler as Chief People Officer 11/29/22 Couchbase announces multi-year strategic collaboration agreement with AWS 11/28/22 Couchbase selected by Arthrex to improve patient outcomes 03/08/23 Arlo Technologies rises 44.3% 03/08/23 Arlo Technologies rises 28.3% 03/08/23 Arlo Technologies rises 16.5% 11/09/22 Arlo Technologies falls -31.9% 03/08/23 Deutsche Bank Crowdstrike price target raised to $130 from $115 at Deutsche Bank 03/08/23 Wedbush Crowdstrike price target raised to $145 from $135 at Wedbush 03/08/23 Stifel Crowdstrike price target raised to $125 from $110 at Stifel 03/08/23 Stephens Crowdstrike price target raised to $173 from $161 at Stephens 12/20/22 Morgan Stanley Campbell Soup price target raised to $57 from $56 at Morgan Stanley 12/08/22 RBC Capital Campbell Soup price target raised to $50 from $46 at RBC Capital 12/08/22 Morgan Stanley Campbell Soup price target raised to $56 from $48 at Morgan Stanley 12/08/22 Piper Sandler Campbell Soup price target raised to $55 from $46 at Piper Sandler 02/22/23 BofA Diversey reinstated with an Underperform at BofA amid near-term challenges 02/22/23 BofA Diversey reinstated with an Underperform at BofA 12/15/22 BMO Capital Diversey initiated with a Market Perform at BMO Capital 11/07/22 Mizuho Diversey price target lowered to $8 from $9 at Mizuho UNFI United Natural Foods $30.49 / -10.48 (-25.58%)
11/29/22 Deutsche Bank United Natural Foods price target raised to $47 from $46 at Deutsche Bank 10/20/22 Goldman Sachs United Natural Foods assumed with a Neutral at Goldman Sachs 09/28/22 MKM Partners United Natural Foods price target lowered to $63 from $69 at MKM Partners 09/28/22 Deutsche Bank United Natural Foods price target lowered to $46 from $54 at Deutsche Bank RIGL Rigel Pharmaceuticals 12/02/22 Citi Citi upgrades Rigel to Buy after leukemia approval comes earlier 12/02/22 Citi Rigel Pharmaceuticals upgraded to Buy from Neutral at Citi 08/18/22 H.C. Wainwright Rigel Pharmaceuticals price target raised to $15 from $7 at H.C. Wainwright 08/16/22 Piper Sandler Rigel Pharmaceuticals price target raised to $2 from $1 at Piper Sandler 03/08/23 Citi Tesla comments 'very bullish' for lithium industry, says Citi 03/08/23 Berenberg Tesla downgraded to Hold from Buy at Berenberg 03/06/23 Morgan Stanley Ferrari replaces Tesla as Morgan Stanley top pick in autos 03/06/23 Jefferies Tesla price target raised to $230 from $180 at Jefferies 03/08/23 Argus Nordstrom upgraded to Buy from Hold at Argus 03/03/23 Morgan Stanley Nordstrom assumed with an Underweight at Morgan Stanley 02/24/23 Citi Nordstrom price target raised to $20 from $17 at Citi 02/24/23 Barclays Nordstrom price target lowered to $16 from $18 at Barclays 03/08/23 Craig-Hallum Craig-Hallum downgrades WW to Sell, sees stock outperformance as overreaction 03/08/23 DA Davidson WW price target raised to $9 from $6 at DA Davidson 03/08/23 Craig-Hallum WW downgraded to Sell from Hold at Craig-Hallum 11/08/22 DA Davidson WW price target lowered to $6 from $15 at DA Davidson 03/08/23 Wells Fargo Wells downgrades Edwards Lifesciences with Medtronic gaining share 03/08/23 Wells Fargo Edwards Lifesciences downgraded to Equal Weight from Overweight at Wells Fargo 02/06/23 Raymond James Edwards Lifesciences downgraded to Market Perform from Outperform at Raymond James 02/06/23 Raymond James Edwards Lifesciences downgraded to Market Perform at Raymond James 02/22/23 Deutsche Bank Medtronic price target raised to $87 from $80 at Deutsche Bank 01/31/23 Bernstein Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein 01/24/23 Mizuho Medtronic price target lowered to $95 from $100 at Mizuho 03/07/23 BofA Cara Therapeutics downgraded to Underperform from Neutral at BofA 03/07/23 Needham Cara Therapeutics price target lowered to $22 from $26 at Needham 03/07/23 Canaccord Cara Therapeutics price target lowered to $25 from $29 at Canaccord 03/07/23 H.C. Wainwright Cara Therapeutics price target lowered to $20 from $25 at H.C. Wainwright 02/06/23 UBS Essential Utilities upgraded to Buy from Neutral at UBS 02/06/23 UBS Essential Utilities upgraded to Buy from Neutral at UBS 09/09/22 BofA Essential Utilities downgraded to Neutral at BofA following PA setbacks 09/09/22 BofA Essential Utilities downgraded to Neutral from Buy at BofA 03/08/23 Macquarie Piedmont Lithium initiated with Outperform, $140 target at Macquarie 03/08/23 Macquarie Piedmont Lithium initiated with an Outperform at Macquarie 12/02/22 DA Davidson Piedmont Lithium price target raised to $90 from $85 at DA Davidson 10/27/22 B. Riley Piedmont Lithium assumed with a Buy at B. Riley 03/06/23 Compass Point Silvergate Capital downgraded to Sell from Neutral at Compass Point 03/06/23 Wedbush Wedbush downgrades Silvergate Capital to Underperform, lowers price target to $4 03/06/23 Wedbush Silvergate Capital downgraded to Underperform from Neutral at Wedbush 03/02/23 Goldman Sachs Goldman suspends Silvergate rating on 'insufficient information' 02/16/23 Piper Sandler WeWork shares should outperform on results, says Piper Sandler 01/03/23 BTIG WeWork named Top Pick for first half of 2023 at BTIG 12/21/22 Cantor Fitzgerald WeWork weakness an attractive buying opportunity, says Cantor Fitzgerald 11/04/22 BTIG WeWork initiated with a Buy at BTIG 03/02/23 Credit Suisse Street revenue estimates need to come down for Micron, says Credit Suisse 03/01/23 Raymond James Intel resumed with an Outperform at Raymond James 02/23/23 Morgan Stanley Intel upgraded to Equal Weight from Underweight at Morgan Stanley 02/22/23 Truist Intel's dividend cut 'not terribly surprising,' says Truist 03/08/23 Roth MKM Maxeon Solar price target raised to $21 from $19 at Roth MKM 03/08/23 Northland Maxeon Solar price target raised to $31 from $24 at Northland 03/08/23 Raymond James Maxeon Solar price target raised to $24 from $22 at Raymond James 01/04/23 Raymond James Maxeon Solar upgraded to Outperform from Market Perform at Raymond James 11/09/22 BWS Financial Arlo Technologies price target lowered to $8 from $15 at BWS Financial 08/10/22 Lake Street Arlo Technologies price target raised to $16 from $14 at Lake Street 01/06/23 Morgan Stanley LifeStance upgraded at Morgan Stanley on confidence in new management 01/06/23 Morgan Stanley LifeStance upgraded to Overweight from Equal Weight at Morgan Stanley 11/14/22 TD Cowen LifeStance price target lowered to $8 from $10 at Cowen 11/07/22 Jefferies LifeStance assumed with a Buy at Jefferies 12/15/22 H.C. Wainwright Opko Health initiated with a Buy at H.C. Wainwright 08/04/22 Piper Sandler Opko Health price target lowered to $4 from $5 at Piper Sandler 05/10/22 Piper Sandler Opko Health price target lowered to $5 from $6 at Piper Sandler 03/07/23 Jefferies Sotatercept data supports bullish view of Merck cardio franchise, says Jefferies 03/07/23 Mizuho Merck cardiovascular franchise set for 'resurgence,' says Mizuho 03/07/23 Raymond James Gossamer Bio downgraded to Market Perform from Outperform at Raymond James 03/06/23 Jefferies Merck initiated with a Buy at Jefferies 03/08/23 Cantor Fitzgerald SoundHound price target raised to $3.20 from $1.60 at Cantor Fitzgerald 01/06/23 Northland SoundHound price target lowered to $4.50 from $6 at Northland 11/30/22 Cantor Fitzgerald SoundHound upgraded to Overweight from Neutral at Cantor Fitzgerald 11/30/22 Cantor Fitzgerald SoundHound upgraded to Overweight from Neutral at Cantor Fitzgerald $15.84 / -2.695 (-14.54%)
03/07/23 BofA Ascendis Pharma has positive read-through from BridgeBio data, says BofA 03/07/23 BofA Tyra Biosciences has positive read-through from BridgeBio data, says BofA 03/07/23 BofA BridgeBio price target raised to $18 from $15 at BofA 03/06/23 Oppenheimer Opco views BridgeBio data as good news for Tyra Biosciences 03/08/23 Morgan Stanley Couchbase conservatism may set up continued quarterly beats, says Morgan Stanley 03/08/23 Stifel Couchbase price target raised to $19 from $17 at Stifel 03/08/23 Baird Couchbase price target raised to $20 from $18 at Baird 02/15/23 Barclays Couchbase price target raised to $19 from $16 at Barclays 12/15/22 Piper Sandler Vita Coco price target raised to $17 from $13 at Piper Sandler 07/08/22 BofA Vita Coco upgraded to Buy at BofA as ocean freight costs ease 07/08/22 BofA Vita Coco upgraded to Buy from Neutral at BofA 05/16/22 Piper Sandler Vita Coco price target lowered to $15 from $17 at Piper Sandler 06/16/22 Noble Capital Vera Bradley initiated with an Outperform at Noble Capital 11/10/22 H.C. Wainwright Minerva downgraded to Neutral from Buy at H.C. Wainwright 10/17/22 JMP Securities Minerva downgraded to Market Perform from Outperform at JMP Securities 08/23/22 H.C. Wainwright Minerva price target lowered to $24 from $40 at H.C. Wainwright 10/10/22 Wedbush Brown-Forman initiated with a Neutral at Wedbush 10/10/22 Wedbush Brown-Forman initiated with a Neutral at Wedbush 02/16/23 Citi Citi launches beverage, personal space with six buys, two sells 02/16/23 Citi Brown-Forman initiated with a Sell at Citi 12/09/22 Barclays Brown-Forman price target lowered to $67 from $73 at Barclays 12/08/22 RBC Capital Brown-Forman price target lowered to $66 from $70 at RBC Capital 03/06/23 WW sees Q1 revenue $235M, consensus $243.89M 03/06/23 WW reports Q4 EPS (46c), consensus 0c 11/03/22 WW sees 2022 revenue $1.04B, consensus $1.06B 11/03/22 WW reports Q3 EPS with items ($2.93), consensus 36c 01/11/23 Essential Utilities sees FY23 EPS $1.85-$1.90, consensus $1.90 01/11/23 Essential Utilities affirms FY22 EPS view of $1.75-$1.80, consensus $1.79 11/07/22 Essential Utilities backs FY22 EPS $1.75-1.80, consensus $1.78 11/07/22 Essential Utilities reports Q3 EPS 26c, consensus 22c 02/16/23 WeWork reports Q4 EPS (59c), consensus (41c) 11/10/22 WeWork sees FY22 revenue $3.35B-$3.37B, consensus $3.37B 11/10/22 WeWork sees Q4 revenue $870M-$890M, consensus $923.83M 11/10/22 WeWork reports Q3 EPS (75c), consensus (45c) 03/08/23 Vera Bradley sees Q1 revenue in line with prior year 03/08/23 Vera Bradley sees 2024 EPS 40c-50c, two est. 35c 03/08/23 Vera Bradley reports Q4 EPS ex-items 16c vs. 17c last year. 01/24/23 Vera Bradley: Pura Vida co-PresidentsThall and Goodman leaving company UNFI United Natural Foods $30.49 / -10.48 (-25.58%)
03/08/23 United Natural Foods cuts FY23 adjusted EPS view to $3.05-$3.90 from $4.85-$5.15 03/08/23 United Natural Foods reports Q2 adjusted EPS 78c, consensus $1.46 12/07/22 United Natural Foods backs FY23 adjusted EPS view $4.85-$5.15, consensus $5.04 12/07/22 United Natural Foods reports Q1 adjusted EPS $1.13, consensus $1.15 03/02/23 Aehr Test Systems reiterates annual guidance, comments on Tesla statements 01/25/23 Tesla reports Q4 EPS $1.19, consensus $1.13 01/25/23 Notable companies reporting after market close 10/19/22 Tesla reports Q3 EPS $1.05, consensus 99c 03/07/23 SoundHound sees FY23 revenue $43M-$50M, consensus $46.05M 03/07/23 SoundHound reports Q4 EPS (15c), consensus (17c) 11/10/22 SoundHound narrows FY22 revenue view $28M-$32M from $27M-$33M 11/10/22 SoundHound reports Q2 EPS (15c) vs (35c) last year 01/17/23 Silvergate Capital reports Q4 adjusted EPS 48c, consensus 81c 10/18/22 Silvergate Capital reports Q3 EPS $1.28, consensus $1.38 RIGL Rigel Pharmaceuticals 03/07/23 Rigel Pharmaceuticals reports Q4 EPS 1c, consensus (11c) 01/09/23 Rigel Pharmaceuticals sees Q4 revenue $51.3M, consensus $21.65M 11/03/22 Rigel Pharmaceuticals reports Q3 EPS (11c), consensus (13c) 02/23/23 Opko Health reports Q4 EPS (11c), consensus (11c) 03/08/23 Minerva reports Q4 EPS ($1.26), consensus (92c) 11/09/22 Minerva reports Q3 EPS ($1.29), consensus ($1.32) 02/28/23 NGM Biopharmaceuticals reports Q4 EPS (45c), consensus (51c) 02/02/23 Merck sees FY23 adjusted EPS $6.80-$6.95, consensus $7.36 02/02/23 Merck reports Q4 adjusted EPS $1.62, consensus $1.54 02/01/23 Notable companies reporting before tomorrow's open 02/21/23 Medtronic sees Q4 EPS $1.55-$1.57, consensus $1.58 02/21/23 Medtronic narrows FY23 EPS view to $5.28-$5.30 from $5.25-$5.30 02/21/23 Medtronic reports Q3 EPS $1.30, consensus $1.27 11/22/22 Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40 03/07/23 Maxeon Solar sees F23 revenue $1.350B-$1.550B, consensus $1.57B 03/07/23 Maxeon Solar sees Q1 revenue $305M-$345M, consensus $309.53M 03/07/23 Maxeon Solar reports Q4 EPS ($1.84), consensus ($1.27) 11/10/22 Maxeon Solar sees Q4 revenue $290M-$330M, consensus $328.34M 03/08/23 LifeStance sees Q1 revenue $242M-$252M, consensus $234.62M 03/08/23 LifeStance sees FY23 revenue $980M-$1.02B, consensus $972.17M 03/08/23 LifeStance reports Q4 revenue $229.4M, consensus $216.61M 11/08/22 LifeStance sees FY22 revenue $845M-$850M, consensus $868.13M 03/02/23 Nordstrom reports Q4 EPS 74c, consensus 66c 03/02/23 Nordstrom sees FY23 adjusted EPS $1.80-$2.20, consensus $1.93 03/02/23 Notable companies reporting after market close 01/19/23 Nordstrom cuts FY22 adjusted EPS view to $1.50-$1.70 from $2.30-$2.60 02/22/23 Intel backs Q1 EPS view (15c), consensus (15c) 02/16/23 Tower Semiconductor not providing Q1 revenue guidance 01/26/23 Intel sees Q1 EPS (15c), consensus 24c 01/26/23 Intel reports Q4 EPS 10c, consensus 20c 01/31/23 Edwards Lifesciences sees Q1 adjusted EPS 58c-64c, consensus 59c 01/31/23 Edwards Lifesciences backs FY23 adjusted EPS $2.45-$2.60, consensus $2.50 01/31/23 Edwards Lifesciences reports Q4 adjusted EPS 64c, consensus 61c 01/31/23 Notable companies reporting after market close 11/03/22 Diversey sees FY22 mid-single digit percent growth over 2021 11/03/22 Diversey reports Q3 adjusted EPS 9c, consensus 9c 03/07/23 Crowdstrike sees FY24 EPS $2.21-$2.39, consensus $2.00 03/07/23 Crowdstrike sees Q1 EPS 50c-51c, consensus 43c 03/07/23 Crowdstrike reports Q4 adjusted EPS 47c, consensus 43c 03/07/23 Notable companies reporting after market close 03/08/23 Campbell Soup tightens FY23 adjusted EPS view to $2.95-$3.00 from $2.90-$3.00 03/08/23 Campbell Soup reports Q2 EPS 80c, consensus 74c 03/07/23 Notable companies reporting before tomorrow's open 03/08/23 Vita Coco sees FY23 net sales growth 9%-11% 03/08/23 Vita Coco reports Q4 EPS (5c), consensus 5c 11/09/22 Vita Coco sees 2022 revenue $422M-$427M, consensus $448.82M 11/09/22 Vita Coco reports Q3 EPS 13c, consensus 15c 03/06/23 Cara Therapeutics reports Q4 EPS (56c), consensus (32c) 11/07/22 Cara Therapeutics reports Q3 EPS (43c), consensus (42c) 03/08/23 Brown-Forman reports Q3 EPS 54c, consensus 47c 12/07/22 Brown-Forman reports Q2 EPS 49c, consensus 55c $15.84 / -2.695 (-14.54%)
02/23/23 BridgeBio reports Q4 EPS (92c), consensus (85c) 11/03/22 BridgeBio reports Q3 EPS (93c), consensus (99c) 03/07/23 Couchbase sees Q1 revenue $39.5M-$40.1M, consensus $40.63M 03/07/23 Couchbase sees FY23 revenue $171.7M-$174.7M, consensus $176.59M 03/07/23 Couchbase reports Q4 EPS (37c), consensus (34c) 03/07/23 Arlo Technologies sees Q1 adjusted EPS (7c)-(1c), consensus (7c) 03/07/23 Arlo Technologies reports Q4 adjusted EPS (4c), consensus (10c)
Hot Stocks
OPKO Health (OPK) entered…
OPKO Health (OPK) entered into an exclusive worldwide license and collaboration agreement with Merck (MRK), known as MSD outside the United States and Canada, for the development of MDX-2201, ModeX's preclinical nanoparticle vaccine candidate targeting EBV. Under the terms of the agreement, OPKO will receive an upfront payment of $50M and is eligible for milestone payments associated with progress in the development and commercialization of MDX-2201 of up to $872.5M , as well as royalties on global sales. ModeX and Merck will jointly advance MDX-2201 to an Investigational New Drug application filing, after which Merck will be responsible for clinical and regulatory activities, as well as product commercialization. "Through the acquisition of ModeX, we broadened our technology foundation and expanded our product pipeline into new therapeutic areas," said Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO. "Merck represents the ideal partner to develop and commercialize a new vaccine candidate, and we are particularly proud to enter into this high-potential agreement so soon after completing the ModeX transaction last May."
Show Hide Related Items >> <<
10/05/22 Aspira Women's Health announces launch of collaboration with BioReferenceOpko Health $111.27 / +0.185 (+0.17%)
03/06/23 Merck says MK-0616 'significantly reduced' LDL-C in Phase 2b study 03/06/23 Merck: FDA approves IM route of administration for MMRV family of vaccines 03/02/23 Illumina and Myriad Genetics partner for HRD testing in the U.S. 03/02/23 AstraZeneca says FDA to convene AdCom meeting on sNDA for Lynparza in mCRPC 12/15/22 H.C. Wainwright Opko Health initiated with a Buy at H.C. Wainwright 08/04/22 Piper Sandler Opko Health price target lowered to $4 from $5 at Piper Sandler 05/10/22 Piper Sandler Opko Health price target lowered to $5 from $6 at Piper Sandler $111.27 / +0.185 (+0.17%)
03/07/23 Jefferies Sotatercept data supports bullish view of Merck cardio franchise, says Jefferies 03/07/23 Mizuho Merck cardiovascular franchise set for 'resurgence,' says Mizuho 03/07/23 Raymond James Gossamer Bio downgraded to Market Perform from Outperform at Raymond James 03/06/23 Jefferies Merck initiated with a Buy at Jefferies 02/23/23 Opko Health reports Q4 EPS (11c), consensus (11c) $111.27 / +0.185 (+0.17%)
02/28/23 NGM Biopharmaceuticals reports Q4 EPS (45c), consensus (51c) 02/02/23 Merck sees FY23 adjusted EPS $6.80-$6.95, consensus $7.36 02/02/23 Merck reports Q4 adjusted EPS $1.62, consensus $1.54 02/01/23 Notable companies reporting before tomorrow's open $111.27 / +0.185 (+0.17%)
02/27/23 Pfizer in talks to buy Seagen in deal that may be valued at over $30B, WSJ says 01/13/23 Johnson & Johnson cuts production of Covid-19 vaccine, WSJ reports 01/11/23 Merck, Pfizer rebuff China's efforts to cut Covid drug prices, Bloomberg says 12/30/22 Merck's Covid treatment gets conditional approval in China, Reuters reports $111.27 / +0.185 (+0.17%)
03/06/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/25/23 Buy/Sell: Wall Street's top 10 stock calls this week 02/23/23 What You Missed On Wall Street On Thursday 02/23/23 What You Missed On Wall Street This Morning $111.27 / +0.185 (+0.17%)
01/10/23 Largest borrow rate increases among liquid names 12/07/22 Largest borrow rate increases among liquid names 11/14/22 Early notable gainers among liquid option names on November 14th 10/10/22 Early notable gainers among liquid option names on October 10th
